Immunohistochemistry revealed that STAT3 expression was strongly associated with lymph node metastasis, TNM staging, and survival, suggesting that STAT3 could function as a predictive biomarker for poor prognosis in GC (Zhang et al., 2017). This evidence concerns the gene STAT3 and metastatic malignant neoplasm in the lymph nodes.